Astrocytic alterations in interleukin-6/soluble interleukin-6 receptor α double-transgenic mice

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1485-1493

  Brunello, Anna G ^a,b   Weissenberger, Jakob ^a   Kappeler, Andreas ^a   Vallan, Claudio ^a   Peters, Malte ^c   Rose John, Stefan ^c   Weis, Joachim ^a,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0033710081     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64787-6     Document Type: Article

References (66)

1. Interleukin-6 in biology and medicine
2. Soluble receptors for cytokines and growth factors: Generation and biological function
3. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
4. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene
5. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells
6. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats
7. Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons
8. Sympathetic neurons can produce and respond to interleukin 6
9. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action
10. Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials
11. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation
12. Accelerated nerve regeneration in mice by upregulated expression of Interleukin (IL) 6 and IL-6 receptor after trauma
13. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization
14. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis
15. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients Neurosci Lett
16. Cytokine gene expression by human gliomas
17. Immune infiltrates and cytokines in gliomas
18. A possible growth factor role of IL-6 in neuroectodermal tumours
19. Castleman's disease of the leptomeninges. Report of three cases
20. Peripheral neuropathy associated with Castleman's disease
21. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome Blood
22. Intracranial Castleman's disease of solitary form. Case report
23. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease
24. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice
25. 'Chordoid' meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome A report of seven cases
26. Structural and functional impact of the transgenic expression of cytokines in the CNS
27. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
28. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice
29. Impaired neuroglial activation in interleukin-6 deficient mice
30. A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury
31. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage
32. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes
33. Neuronal activities of IL-6-type cytokines often depend on soluble cytokine receptors
34. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
35. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice
36. The function of the soluble IL-6 receptor in viva
37. Introns increase transcriptional efficiency in transgenic mice
38. Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice
39. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
40. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas
41. Production of hybridoma growth factor by human monocytes
42. Mitochondrial abnormalities and intrafamilial variability of sural nerve biopsy findings in adrenomyeloneuropathy
43. The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
44. The functional significance of brain metallothioneins
45. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice
46. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression
47. Extramedullary expansion of hematopoietic progenitor cells in Interleukin (IL)-6-sIL-6R double transgenic mice
48. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice
49. Physiological and pathological roles of interleukin-6 in the central nervous system
50. Astrocytes induce blood-brain barrier properties in endothelial cells
51. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes
52. Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia
53. The influence of cytokines on the integrity of the blood-brain barrier in vitro
54. Parenchymal changes related to plasma protein extravasation in experimental seizures
55. A transient hypertensive opening of the blood-brain barrier can lead to brain damage. Extravasation of serum proteins and cellular changes in rats subjected to aortic compression
56. The role of central nervous system endothelial cell activation in the pathogenesis of hepatic encephalopathy
57. The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo
58. Penetration of interleukin-6 across the routine blood-brain barrier
59. Passage of cytokines across the blood-brain barrier
60. Saturable entry of ciliary neurotrophic factor into brain
61. Granulocyte macrophage-colony stimulating factor crosses the blood-testis barrier in mice
62. Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor
63. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver